GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_619/2025 and UPC_CFI_1526/2025

GlaxoSmithKline Biologicals SA v. Moderna et al.

Datum
2025-11-28
Kammer
The Hague (NL) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_619-2025-and-UPC_CFI_1526-2025-ea5da3b38508
Aktenzeichen
RegisterzeichenUPC_CFI_619/2025 and UPC_CFI_1526/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 The Hague - Local Division UPC_CFI_619/2025 UPC_CFI_1526/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 28/11/2025 concerning R.302 CLAIMANT/S 1) GlaxoSmithKline Biologicals SA (“Claimant”) - Rue de l'Institut 89 - 1330 - Rixensart - BE Represented by Tjibbe Douma DEFENDANT/S 1) Moderna Netherlands B.V. (Defendant) - Claude Debussylaan 7 - 1082 MC - Amsterdam - NL 2) Moderna Biotech Spain, S.L. (Defendant) - C/Julián Camarillo 31 - 28037 - Madrid - ES 3) Moderna Biotech UK Limited (Defendant) - 54 Portland Place - W1B 1DY - London - GB 4) Moderna Biotech Distributor UK Ltd (Defendant) - MYO, 123 Victoria Street - SW1E 6DE - London - GB 2 5) Moderna Switzerland GmbH (Defendant) - Peter Merian-Weg 10 - 4052 - Basel - CH 6) Moderna Poland SP. Z ...